Company page

Apex Biotechnology Corp.

Apex Biotechnology Corp. is a publicly traded company on the Taiwan stock market under the ticker 1733. The company has a market capitalization of approximately 97.6 million USD. Apex Biotechnology focuses on the development and production of innovative medical technologies and solutions.

profile1733AI content: aiUpdated June 12, 2026/company/apex-biotechnology-corp
Apex Biotechnology Corp. logo
Ticker
1733
Market cap
$91.9M
Sector
Health Technology
Industry
Biotechnology